Muench R, Buehler H, Kehl O, Ammann R
Pancreas. 1987;2(3):333-8. doi: 10.1097/00006676-198705000-00013.
Lipase, in contrast to amylase, is completely reabsorbed by the proximal tubules after glomerular filtration. Therefore, no lipase is detectable in the unconcentrated urine according to the current opinion. The handling of lipase (detected with an enzyme-immunoassay) by the kidney was investigated in comparison with creatinine, amylase, and beta-2-microglobulin by clearance studies in acute pancreatitis (n = 10), burn injury (n = 4), glomerular proteinuria (n = 8), and controls without evidence of pancreatic or renal diseases (n = 5). In initial stages of acute pancreatitis a measurable clearance of lipase (mean: 49.6 microliters/min, range: 0.5-234) was found in association with corresponding increased clearances of beta-2-microglobulin (mean: 10.5 ml/min, range: 0.02-58.9) and of amylase (mean: 8.9 ml/min, range: 2.4-22.6) in nine of ten patients. This finding is consistent with a defect of tubular function. However, regression analysis failed to show a significant correlation between lipase and beta-2-microglobulin clearance. Repeated measurements during the course of pancreatitis in seven patients showed reversibility of tubular dysfunction. In patients with burn injury a similar elevation of clearances of beta-2-microglobulin and of amylase was found, but tubular dysfunction in this condition was not associated with lipasuria. In glomerular proteinuria a lipase clearance was found in two of five cases with moderate, and in the other three cases with severe impairment of creatinine clearance. beta-2-microglobulin clearance was normal in the former and only slightly elevated in the latter group. In conclusion lipase is measurable in the urine of most patients with acute pancreatitis as a result of a reversible tubular dysfunction.(ABSTRACT TRUNCATED AT 250 WORDS)
与淀粉酶不同,脂肪酶在肾小球滤过后被近端小管完全重吸收。因此,按照目前的观点,在未浓缩的尿液中检测不到脂肪酶。通过对急性胰腺炎(n = 10)、烧伤(n = 4)、肾小球蛋白尿(n = 8)患者以及无胰腺或肾脏疾病证据的对照组(n = 5)进行清除率研究,将用酶免疫测定法检测到的脂肪酶与肌酐、淀粉酶和β2-微球蛋白进行比较,以研究肾脏对脂肪酶的处理情况。在急性胰腺炎的初始阶段,在10例患者中的9例中发现脂肪酶清除率可测(平均:49.6微升/分钟,范围:0.5 - 234),同时β2-微球蛋白清除率相应增加(平均:10.5毫升/分钟,范围:0.02 - 58.9),淀粉酶清除率也增加(平均:8.9毫升/分钟,范围:2.4 - 22.6)。这一发现与肾小管功能缺陷一致。然而,回归分析未能显示脂肪酶与β2-微球蛋白清除率之间存在显著相关性。对7例胰腺炎患者病程中的重复测量显示肾小管功能障碍具有可逆性。在烧伤患者中也发现了β2-微球蛋白和淀粉酶清除率的类似升高,但这种情况下的肾小管功能障碍与脂肪酶尿无关。在肾小球蛋白尿患者中,5例肌酐清除率中度受损的患者中有2例出现脂肪酶清除率升高,另外3例肌酐清除率严重受损的患者中也出现脂肪酶清除率升高。前一组患者的β2-微球蛋白清除率正常,后一组仅略有升高。总之,由于可逆性肾小管功能障碍,大多数急性胰腺炎患者的尿液中可检测到脂肪酶。(摘要截短于250字)